Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial

Luis G Paz-Ares, Mikhail Vladimirovich Dvorkin, Yuanbin Chen et al. · The Lancet · 2019

Cited by 2,279 works. doi:10.1016/s0140-6736(19)32222-6

Authors

References